ClinicalTrials.gov
public full text
Public Domain
Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke
The aim of the study is to investigate treatment with Leukostim (Filgrastim; granulocyte-colony stimulating factor; G-CSF) for acute ischemic stroke.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke#841565
- Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant#862547
- Early peripheral blood gene expression associated with good and poor 90-day ischemic stroke outcomes#1174806
- Glioblastoma Platelet Activation Study#1071922
- The Screening of Neuroprotective Biomarkers After Acute Ischemic Stroke#806349
Record · ID 877992
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive